Publications (57) Publications in which a researcher has participated

2023

  1. A Novel Mouse Model of Combined Hepatocellular-Cholangiocarcinoma Induced by Diethylnitrosamine and Loss of Ppp2r5d

    Cancers, Vol. 15, Núm. 16

  2. Advancing with cancer immunotherapeutics: CD29+ regulatory T cell antagonism

    Gut

  3. Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice

    Cell Death and Disease, Vol. 14, Núm. 8

  4. Expression of HMGCS2 in intestinal epithelial cells is downregulated in inflammatory bowel disease associated with endoplasmic reticulum stress

    Frontiers in immunology, Vol. 14, pp. 1185517

  5. Hepatocyte dedifferentiation profiling in alcohol-related liver disease identifies CXCR4 as a driver of cell reprogramming

    Journal of Hepatology, Vol. 79, Núm. 3, pp. 728-740

  6. JNKs protect from cholestatic liver disease progression by modulating Apelin signalling

    JHEP Reports, Vol. 5, Núm. 11

  7. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1869, Núm. 4

  8. Mouse Models for Hepatic Stellate Cell Activation and Liver Fibrosis Initiation

    Methods in molecular biology (Clifton, N.J.), Vol. 2669, pp. 177-191

  9. Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

    Cell death & disease, Vol. 14, Núm. 8, pp. 514

  10. Novel therapeutic avenues for the study of chronic liver disease and regeneration: The foundation of the Iberoamerican Consortium for the study of liver Cirrhosis

    Gastroenterologia y Hepatologia